RTTNews | Oct 6, 2020 06:35AM EDT

06:34 Tuesday, October 6, 2020 (RTTNews) - Affimed Doses First Patient In Phase 1 Clinical Trial Of Cord Blood-derived Natural Killer Cells With AFM13

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved